April 2017 Vol 8, No 4

If new drug approvals are any indication, personalized medicine will be a significant part of oncology navigation in the coming years.
Constant exposure to patient distress and trauma can take a toll on oncology workers, and it often leads to a phenomenon called secondary traumatic stress, or “compassion fatigue,” according to Charles Figley, PhD, Paul Henry Kurzweg Chair in Disaster Mental Health and Director of the Traumatology Institute at Tulane University in New Orleans, LA.
Adding vemurafenib to cetuximab and irinotecan prolonged progression-free survival (PFS) and improved the disease control rate in patients with BRAF V600E mutation–positive colorectal cancer (CRC).
Despite consultations with oncologists about the goal of treatment, more than one-third of men with incurable prostate cancer believed that a cure was possible with the treatments they were about to receive.
A beautiful case study exemplifying the power of navigation when executed in collaboration with the patient, caregivers and care team.
Page 1 of 2
Results 1 - 10 of 16

Subscribe to the Journal of Oncology Navigation & Survivorship®

To sign up for our print publication or e-newsletter, please enter your contact information below.

  • First Name *
    Last Name *
     
    Country
  • Please enter your mailing address.

    Address
     
    Address Line 2
    City
     
    State
    Zip Code